Ovarian Cancer
What Is Ovarian Cancer?
Ovarian cancer develops within the ovaries, the reproductive organs responsible for producing eggs, and can also arise from related structures including the fallopian tubes and peritoneum.1
Approximately ten percent of ovarian cancer cases are hereditary, with women carrying BRCA1 or BRCA2 gene mutations facing an approximately fifty percent lifetime risk of developing the disease.2
Ovarian cancer often produces no early symptoms, meaning the disease is frequently advanced by the time diagnosis occurs.
About 10% of ovarian cancer cases are hereditary, and those with BRCA1 and BRCA2 gene mutations have an approximately 50% risk of developing the disease.
National Cancer Institute
Symptoms
Ovarian cancer may not cause early signs or symptoms, and when symptoms do eventually appear, the cancer has often already progressed to an advanced stage.
Symptoms can include pain, swelling, or pressure in the abdomen or pelvis, along with urinary urgency or frequency, and difficulty eating or feeling full quickly.
Additional symptoms include a palpable lump in the pelvic area and gastrointestinal complaints such as gas, bloating, or constipation, which are often mistakenly attributed to less serious digestive issues.
Causes
Ovarian cancer occurs more frequently in women who ovulate more often over their lifetime, meaning women who have never had children face increased risk.
This connection between ovulation frequency and cancer risk helps explain why factors reducing lifetime ovulation, such as pregnancy and breastfeeding, are associated with reduced risk.
Genetic factors, particularly inherited mutations in the BRCA1 and BRCA2 genes, represent an important and well established cause in a meaningful subset of diagnosed cases.2
Risk Factors
Additional risk factors include hormone therapy after menopause, use of fertility medications, smoking, and obesity.
Factors that decrease ovarian cancer risk include use of hormonal birth control, tubal ligation, and breastfeeding, all of which reduce lifetime ovulation frequency.
Women with a family history suggestive of hereditary breast and ovarian cancer syndrome benefit from genetic counseling and testing to clarify their individual risk profile.2
Complications
Because ovarian cancer often causes no early symptoms, delayed diagnosis contributes significantly to the disease’s overall prognosis compared to cancers detected earlier.
Diagnosis typically begins with physical examination, blood testing for CA-125 and other tumor markers, and transvaginal ultrasound imaging.1
Currently, no strong evidence supports that routine ovarian cancer screening using CA-125 testing and transvaginal ultrasound leads to earlier detection or improved outcomes in average risk women.1
Treatment
Treatment for ovarian cancer often includes some combination of surgery, radiation therapy, and chemotherapy, selected based on cancer stage and individual patient factors.1
For women carrying BRCA1 or BRCA2 mutations, risk reducing surgery, including removal of the ovaries and fallopian tubes, has been shown to significantly reduce the risk of developing ovarian cancer.2
This preventive surgical approach represents an important option for high risk women, discussed carefully alongside considerations of fertility and hormonal health.2
Prevention
For women at average risk, use of hormonal birth control has been associated with reduced ovarian cancer risk over time.
Genetic counseling and testing for women with significant family history supports identification of hereditary risk, allowing for informed decisions about risk reducing strategies.2
For confirmed BRCA1 or BRCA2 mutation carriers, risk reducing surgery represents the most effective available prevention strategy once childbearing is complete.2
Why Visual Communication Matters for Ovarian Cancer
Explaining why ovarian cancer often goes undetected until an advanced stage requires visuals that clearly convey ovarian anatomy and the limitations of current screening approaches.
Pharmaceutical companies, gynecologic oncology practices, and patient education organizations rely on precise illustration and animation to explain ovarian cancer risk, diagnosis, and treatment.
- Illustrating ovarian anatomy and cancer development
- Animating the connection between ovulation frequency and cancer risk
- Explaining BRCA gene mutations and hereditary risk assessment
- Visualizing risk reducing surgery and its protective effect
- Supporting patient education on symptom awareness and genetic counseling
- Creating training materials for gynecologic oncology clinicians
How Biotic Artlab Supports Ovarian Cancer Communication
We work with pharmaceutical companies, gynecologic oncology practices, and healthcare organizations to create scientifically accurate visuals that make ovarian cancer easier to understand.
- Custom 3D animations of ovarian anatomy and cancer development
- Detailed illustrations of BRCA related hereditary risk
- Visualizations of risk reducing surgical options
- Patient facing materials on symptom awareness and genetic testing
- Clinical training content for gynecologic oncology teams
- Conference presentations and marketing visuals for women’s health audiences
Frequently Asked Questions
What are common symptoms of ovarian cancer?
Abdominal pain, bloating, urinary urgency, and early satiety are common symptoms, though they often appear late.
What is the connection between BRCA mutations and ovarian cancer?
BRCA1 and BRCA2 mutation carriers face approximately a fifty percent lifetime risk of developing ovarian cancer.2
Is there an effective ovarian cancer screening test?
No strong evidence currently supports that routine CA-125 and ultrasound screening improves outcomes in average risk women.1
What reduces ovarian cancer risk?
Hormonal birth control use, tubal ligation, and breastfeeding are all associated with reduced risk.
How is ovarian cancer treated?
Treatment typically combines surgery, chemotherapy, and sometimes radiation therapy.1
Can risk reducing surgery help high risk women?
Yes, removal of the ovaries and fallopian tubes significantly reduces risk in BRCA mutation carriers.2
Have a Project in Mind? Contact Us.
If you are developing patient education materials, clinical training content, or marketing visuals related to ovarian cancer, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.
References
- National Cancer Institute. Treatment of Ovarian Epithelial, Fallopian, and Peritoneal Cancers.
- National Cancer Institute. Genetics of Breast and Gynecologic Cancers.
Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, or individualized advice from a qualified healthcare professional.